by Benzinga Insights | Sep 12, 2026 | General
Synopsys (NASDAQ:SNPS) has outperformed the market over the past 10 years by 7.57% on an annualized basis producing an average annual return of 21.14%. Currently, Synopsys has a market capitalization of $76.19 billion. Buying $1000 In SNPS: If an investor had bought...
by Benzinga Insights | Sep 12, 2026 | General
Morgan Stanley (NYSE:MS) has outperformed the market over the past 10 years by 7.4% on an annualized basis producing an average annual return of 20.97%. Currently, Morgan Stanley has a market capitalization of $336.96 billion. Buying $100 In MS: If an investor had...
by Benzinga Insights | Sep 11, 2026 | General
Intuitive Surgical (NASDAQ:ISRG) has outperformed the market over the past 10 years by 3.55% on an annualized basis producing an average annual return of 17.12%. Currently, Intuitive Surgical has a market capitalization of $132.12 billion. Buying $1000 In ISRG: If an...
by Benzinga Insights | Sep 11, 2026 | General
Marvell Technology (NASDAQ:MRVL) has outperformed the market over the past 10 years by 20.52% on an annualized basis producing an average annual return of 34.08%. Currently, Marvell Technology has a market capitalization of $211.91 billion. Buying $1000 In MRVL: If an...
by Benzinga Insights | Sep 11, 2026 | General
Cencora (NYSE:COR) has outperformed the market over the past 10 years by 6.79% on an annualized basis producing an average annual return of 20.35%. Currently, Cencora has a market capitalization of $61.36 billion. Buying $1000 In COR: If an investor had bought $1000...
by Benzinga Insights | Sep 11, 2026 | General
ExxonMobil Holdings (NYSE:XOM) has outperformed the market over the past 5 years by 13.45% on an annualized basis producing an average annual return of 24.91%. Currently, ExxonMobil Holdings has a market capitalization of $691.44 billion. Buying $100 In XOM: If an...
Recent Comments